本文へ移動
cccskills
無料GitHub で公開

endo-csii-cgm-education-training-support

Suggests that adults with type 1 or type 2 diabetes using continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) receive education, training, and ongoing support to achieve and maintain individualized glycemic goals. Trigger phrases include: 'Patient on pump plus CGM, arrange education' and 'Ensure CSII+CGM users get training and support'.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md3.5 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Suggest education/training/support for CSII and CGM users

STEP 1 — Gather Information

Collect patient demographics, diabetes type, current therapy (CSII + CGM), baseline A1C, hypoglycemia history, glucose variability, willingness/ability to use devices, self-care behaviors (carb counting, SMBG/CGM frequency, infusion site health, DKA prevention, hypoglycemia detection/treatment, emergency supplies, bolus calculator settings if used), insurance coverage, and follow-up availability.
Action: Proceed to assess need for CSII/CGM education and training.

STEP 2 — Rule In / Rule Out

Determine if the patient is using both CSII and CGM. If yes, rule in for education/training/support; if either is missing, rule out (no further action under this skill).
Decision: If both CSII and CGM are used, advance to classification; otherwise, stop here.

STEP 3 — Classify or Stratify

Classify the user by experience level (new initiate vs experienced) and specific deficits (e.g., bolus calculator training, hypoglycemia awareness, infusion site rotation, trend data interpretation) using Table 1 (CSII considerations) and Table 2 (RT-CGM considerations) from the guideline.
Action: Select appropriate education modules based on classification.

STEP 4 — Decide

Implement an individualized education/training plan: provide initial comprehensive training, schedule periodic reassessment (annually or when upgrading device), involve a multidisciplinary diabetes team, deliver hands‑on device training, review troubleshooting and emergency planning, and ensure access to written instructions and support resources.
Action: Arrange follow‑up education and support as per the individualized plan.

Clinical Guardrails / Mimics / Pitfalls

  • Do not assume prior knowledge; always verify competency before considering training complete.
  • Do not skip formal education when upgrading to new CSII or CGM technology; vendor‑only training is insufficient.
  • Ensure hypoglycemia prevention, detection, and treatment are covered in every education session.
  • Assess cognitive, visual, dexterity, and mental health factors that may affect device operation.
  • Verify insurance coverage and access to supplies; lack of access undermines training effectiveness.
  • Avoid relying solely on self‑directed learning; structured clinician‑led education improves outcomes.

Concrete Clinical Example

A 48‑year‑old with type 1 diabetes using CSII and RT‑CGM reports two severe hypoglycemic episodes in the past month. Review shows suboptimal carb counting, outdated bolus calculator ratios, and infrequent infusion site rotation. Provide focused refresher training on carbohydrate counting, bolus calculator adjustment, trend‑based insulin dosing, alarm settings, and site rotation. Schedule quarterly check‑ins to reinforce skills and adjust support as needed.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults, Endocrine Society Clinical Practice Guideline, 2016, doi:10.1210/jc.2016-2534.

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する